Research Analysts Issue Forecasts for ZVRA FY2025 Earnings
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Equities research analysts at Cantor Fitzgerald reduced their FY2025 earnings per share (EPS) estimates for shares of Zevra Therapeutics in a report issued on Wednesday, March 12th. Cantor Fitzgerald analyst K. Kluska now forecasts that the company will post earnings per share of ($0.24) for the year, […]
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Equities research analysts at Cantor Fitzgerald reduced their FY2025 earnings per share (EPS) estimates for shares of Zevra Therapeutics in a report issued on Wednesday, March 12th. Cantor Fitzgerald analyst K. Kluska now forecasts that the company will post earnings per share of ($0.24) for the year, […]
